Dermatophytosis
📧 Sign up to get email alerts when something new happens for Dermatophytosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Comparison of Combination of Itraconazole and Isotretinoin Versus Itraconazole Alone in the Treatment of Resistant Trichophyton Infection [NA]
A completed clinical trial compares adding isotretinoin to itraconazole versus itraconazole alone for resistant Trichophyton infections.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis [Phase 4]
A Phase 4 clinical trial comparing oral fluconazole with oral itraconazole for resistant tinea corporis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Evaluation of Two Dermatophyte qPCR Kits on Skin and Keratinous Samples.
A completed clinical trial evaluated two dermatophyte qPCR kits for detecting dermatophyte infections on skin and keratinous samples.
-
FDA approval · 2025-09-12FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Terbinafine hydrochloride from Bionpharma Inc., approving a generic antifungal product under the…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Fungal Resistance in Dermatophyte Infection
A Cairo University-sponsored clinical trial on fungal resistance in dermatophyte infections is currently NOT_YET_RECRUITING.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-20FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Ultramicrosize Griseofulvin tablets from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2025-03-07FDA Approved: KETOCONAZOLE — Original Application (Viona Pharmaceuticals Inc)
FDA approves the Original Application for Ketoconazole submitted by Viona Pharmaceuticals Inc, granting approval of a generic ketoconazole p…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections [Phase 2]
A Phase 2 study is planned to evaluate oral voriconazole for resistant dermatophyte infections, with recruitment not yet started.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Novel Electrolyzed Water Spray Treatment Mild Dermatophytosis [NA]
Clinical trial update indicating completion of a study evaluating a novel electrolyzed water spray for mild dermatophytosis.
-
FDA approval · 2021-08-17FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for a topical Nystatin and Triamcinolone Acetonide product from Macleods Pharmaceuticals Limited for t…
-
FDA approval · 2020-07-06FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's supplemental approval for the clotrimazole and betamethasone dipropionate topical product. The action approves…
-
FDA approval · 2020-05-29FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc. USA)
FDA approved a supplemental application for clotrimazole and betamethasone dipropionate from Glenmark Pharmaceuticals USA, authorizing an up…
-
FDA approval · 2019-07-25FDA Approved: CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% — Original Application (TruPharma LLC)
FDA approved TruPharma LLC's clotrimazole topical solution 1% as an original application (ANDA) for treatment of common cutaneous fungal inf…
-
CLINICAL_TRIALS research · 2019-03-19Clinical Trial Update: Study Evaluating the Effect of Jublia on Dermatophytomas [Phase 4]
Phase 4 trial investigating the effect of Jublia on dermatophytomas in onychomycosis and dermatophytosis.
-
FDA approval · 2018-05-31FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves the original application for the generic topical combination Nystatin and Triamcinolone Acetonide by Lupin Pharmaceuticals for …
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis [Phase 2]
A Phase 2 trial evaluating isotretinoin to prevent recurrences in chronic dermatophytosis (tinea) is listed with unknown status.
-
FDA approval · 2018-04-18FDA Approved: ECONAZOLE NITRATE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for econazole nitrate from Aurobindo Pharma Limited, enabling a generic topical antifungal product.
-
FDA approval · 2017-08-14FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a generic Nystatin and Triamcinolone Acetonide Cream under an Original Application by Padagis Israel Pharmaceuticals Ltd. It is…
-
FDA approval · 2016-12-20FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Padagis Israel Pharmaceuticals Ltd's Nystatin and Triamcinolone Acetonide as an Original Application (ANDA) for a topical antif…
-
FDA approval · 2016-10-24FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's Nystatin and Triamcinolone Acetonide as an Original Application (ANDA) for a topical combination product indicated f…
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Superficial and Cutaneous Fungal Infections Among Drug-users in Northeast Region of Iran
Completed clinical trial in northeast Iran studying superficial and cutaneous fungal infections among drug users; results have been posted.
-
FDA approval · 2015-08-31FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)
FDA approved a supplemental application for Ketoconazole from Thirty Madison Inc under an existing ANDA, signaling an approved modification …
-
FDA approval · 2015-07-15FDA Approved: ECONAZOLE NITRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for econazole nitrate from Sun Pharmaceutical Industries, Inc., resulting in an approved update rela…
-
FDA approval · 2015-03-03FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for OXISTAT (oxiconazole nitrate) submitted by ANI Pharmaceuticals. The update modifies the labe…
-
FDA approval · 2015-01-05FDA Approved: CLOTRIMAZOLE — Supplemental Application (Rite Aid Corporation)
FDA approved a supplemental application for clotrimazole submitted by Rite Aid Corporation, indicating an updated/expanded approval for this…